Etoricoxib Cinfa 60 mg film-coated tablets EFG

Patient Information Leaflet

Introduction

Patient Information Leaflet

Etoricoxib cinfa 30 mg film-coated tablets EFG

Etoricoxib cinfa 60 mg film-coated tablets EFG

Etoricoxib cinfa 90 mg film-coated tablets EFG

Etoricoxib cinfa 120 mg film-coated tablets EFG

Read the entire leaflet carefully before you start taking this medicine, as it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only and must not be given to other people, even if they have the same symptoms as you, since it may harm them.
• If you experience any adverse effects, consult your doctor or pharmacist, even if such effects are not listed in this leaflet. See section 4.

Leaflet Contents

1. What Etoricoxib cinfa is and what it is used for
2. What you need to know before taking Etoricoxib cinfa
3. How to take Etoricoxib cinfa
4. Possible adverse effects
5. How to store Etoricoxib cinfa
6. Contents of the pack and other information

1. What Etoricoxib cinfa is and what it is used for

What is Etoricoxib cinfa?

• Etoricoxib cinfa contains the active substance etoricoxib. Etoricoxib cinfa belongs to a group of medicines known as selective COX-2 inhibitors. These belong to a family of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).

What is Etoricoxib cinfa used for?

• Etoricoxib cinfa helps reduce pain and swelling (inflammation) in the joints and muscles of individuals aged 16 years and older with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and gout.
• Etoricoxib cinfa is also used for the short-term treatment of moderate pain following dental surgery in individuals aged 16 years and older.

What is osteoarthritis?

Osteoarthritis is a joint disease. It causes the gradual breakdown of the cartilage that cushions the ends of bones. This leads to swelling (inflammation), pain, tenderness, stiffness, and loss of function.

What is rheumatoid arthritis?

Rheumatoid arthritis is a long-term inflammatory disease of the joints. It causes pain, stiffness, swelling, and progressive loss of mobility in affected joints. It can also cause inflammation in other parts of the body.

What is gout?

Gout is a condition characterized by sudden and recurring attacks of very painful inflammation and redness in the joints. It is caused by deposits of mineral crystals in the joint.

What is ankylosing spondylitis?

Ankylosing spondylitis is an inflammatory disease affecting the spine and large joints.

2. What you need to know before starting to take Etoricoxib cinfa

Do not take Etoricoxib cinfa

• if you are allergic to etoricoxib or to any of the other ingredients of this medicine (listed in section 6)
• if you are allergic to non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and COX-2 inhibitors (see Possible side effects, section 4)
• if you currently have a stomach or duodenal ulcer or bleeding
• if you have severe liver disease
• if you have severe kidney disease
• if you are or may be pregnant, or are breastfeeding your child (see "Pregnancy, breastfeeding and fertility")
• if you are under 16 years of age
• if you have inflammatory bowel disease, such as Crohn's disease, ulcerative colitis or colitis
• if you have high blood pressure that has not been controlled with treatment (consult your doctor or nurse if you are unsure whether your blood pressure is adequately controlled)
• if your doctor has diagnosed you with heart problems including heart failure (moderate or severe), angina (chest pain)
• if you have had a myocardial infarction, surgical revascularization, or peripheral arterial disease (poor circulation in the legs or feet due to narrowed or blocked arteries)
• if you have had any type of stroke (including transient ischaemic attack or ischaemic stroke).
• Etoricoxib may slightly increase your risk of myocardial infarction and stroke, and therefore should not be used in patients who have already had heart problems or a stroke.

If you think any of these apply to you, do not take the tablets until you have consulted your doctor.

Warnings and precautions

Talk to your doctor or pharmacist before starting to take Etoricoxib cinfa

• If you have a history of stomach ulcers or gastrointestinal bleeding.
• If you are dehydrated, for example, due to a prolonged illness with vomiting or diarrhoea.
• If you have swelling due to fluid retention.
• If you have a history of heart failure or any other form of heart disease.
• If you have a history of high blood pressure. Etoricoxib may increase blood pressure in some people, especially at high doses, and your doctor will want to check your blood pressure from time to time.
• If you have a history of liver or kidney disease.
• If you are being treated for an infection. Etoricoxib may mask or hide fever, which is a sign of infection.
• If you have diabetes, high cholesterol, or are a smoker, as these may increase your risk of heart disease.
• If you are a woman trying to become pregnant.
• If you are over 65 years of age.

If you are not sure whether any of the above situations apply to you, talk to your doctor before taking etoricoxib to check whether this medicine is suitable for you.

Etoricoxib works equally well in young and older adult patients. If you are over 65 years of age, your doctor will want to monitor you appropriately. Dose adjustment is not necessary in patients over 65 years of age.

Children and adolescents

Do not give this medicine to children and adolescents under 16 years of age.

Taking Etoricoxib cinfa with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken or might need to take any other medicines, including those obtained without a prescription.

In particular, if you are taking any of the following medicines, your doctor may want to monitor you to ensure your medicines are working properly once you start taking etoricoxib:

• medicines that make your blood less thick (anticoagulants), such as warfarin

• rifampicin (an antibiotic)

• methotrexate (a medicine used to suppress the immune system and often used in rheumatoid arthritis)

• ciclosporin or tacrolimus (medicines used to suppress the immune system)

• lithium (a medicine used to treat certain types of depression)

• medicines used to help control high blood pressure and heart failure called ACE inhibitors and angiotensin receptor antagonists, for example enalapril and ramipril, losartan and valsartan

• diuretics (water tablets)

• digoxin (a medicine for heart failure and irregular heartbeat)

• minoxidil (a medicine used to treat high blood pressure)

• tablets or oral solution of salbutamol (a medicine for asthma)

• oral contraceptives (the combination may increase your risk of side effects)

• hormone replacement therapy (the combination may increase your risk of side effects)

• aspirin: the risk of stomach ulcers is higher if you take etoricoxib with aspirin.

  • Aspirin for prevention of myocardial infarction or stroke:

etoricoxib can be taken with low doses of aspirin. If you are currently taking low-dose aspirin to prevent myocardial infarction or stroke, do not stop taking aspirin without first talking to your doctor.

• Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs):

do not take high doses of aspirin or other anti-inflammatory medicines while taking etoricoxib.

Taking Etoricoxib cinfa with food and drink

The onset of etoricoxib's effect may be faster if taken without food.

Pregnancy, breastfeeding and fertility

Pregnancy

Etoricoxib tablets should not be taken during pregnancy. Do not take the tablets if you are pregnant, think you may be pregnant, or plan to become pregnant. If you become pregnant, stop taking the tablets and consult your doctor. Speak to your doctor if you have any doubts or need further information.

Breastfeeding

It is not known whether etoricoxib is excreted in human milk. If you are breastfeeding or plan to breastfeed, consult your doctor before taking etoricoxib. If you are taking etoricoxib, you should not breastfeed.

Fertility

Etoricoxib is not recommended for use in women attempting to become pregnant.

Driving and using machines

Dizziness and somnolence have been reported in some patients taking etoricoxib.

Do not drive if you experience dizziness or somnolence.

Do not use tools or machines if you experience dizziness or somnolence.

Etoricoxib cinfa contains sodium.

This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free".

3. How to take Etoricoxib cinfa

Follow exactly the instructions for use of this medicine provided by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

Do not take more than the recommended dose for your condition. Your doctor will want to review your treatment from time to time. It is important to use the lowest dose that controls your pain, and you should not take etoricoxib for longer than necessary. This is because the risk of heart attacks and strokes may increase after prolonged treatment, especially with high doses.

Different doses of this medicine are available, and depending on your condition, your doctor will prescribe the tablet with the dose appropriate for you.

The recommended dose is:

Osteoarthritis

The recommended dose is 30 mg once daily, increasing up to a maximum of 60 mg once daily if necessary.

Rheumatoid arthritis

The recommended dose is 60 mg once daily, increasing up to a maximum of 90 mg once daily if necessary.

Ankylosing spondylitis

The recommended dose is 60 mg once daily, increasing up to a maximum of 90 mg once daily if necessary.

Acute pain situations

Etoricoxib should only be used during the period of acute pain.

Gout

The recommended dose is 120 mg once daily, which should only be used during the period of acute pain, limited to a maximum of 8 days of treatment.

Postoperative dental surgery pain

The recommended dose is 90 mg once daily, limited to a maximum of 3 days of treatment.

Patients with liver problems

• If you have mild liver disease, you should not take more than 60 mg per day.
• If you have moderate liver disease, you should not take more than 30 mg per day.

Use in children and adolescents

Children or adolescents under 16 years of age must not take etoricoxib tablets.

Patients aged 65 years and older

Dose adjustment is not necessary in patients aged 65 years and older. However, as with other medicines, caution should be exercised in elderly patients.

Method of administration

Etoricoxib is administered orally. Take the tablets once daily. Etoricoxib can be taken with or without food.

If you take more Etoricoxib cinfa than you should

You must never take more tablets than your doctor has recommended. If you take too many etoricoxib tablets, seek immediate medical attention.

In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service at 91 562 04 20, indicating the medicine and the amount ingested. It is recommended to bring the medicine packaging and leaflet to the healthcare professional.

If you forget to take Etoricoxib cinfa

It is important that you take etoricoxib as directed by your doctor. If you miss a dose, simply resume your regular dosing schedule the next day. Do not take a double dose to make up for a missed dose.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

If you develop any of the following signs, stop taking etoricoxib and speak to your doctor immediately (see section 2. What you need to know before taking Etoricoxib cinfa):

• difficulty breathing, chest pain, or ankle swelling, or if these worsen
• yellowing of the skin and eyes (jaundice) – these are signs of liver problems
• severe or persistent stomach pain or black stools
• an allergic reaction – which may include skin problems such as ulcers or blistering, or swelling of the face, lips, tongue, or throat that may cause difficulty breathing

The frequency of the possible adverse effects listed below is defined according to the following classification:

Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)

The following adverse effects may occur during treatment with etoricoxib:

Very common

• stomach pain

Common

• dry socket (inflammation and pain following tooth extraction)
• swelling of the legs and/or feet due to fluid retention (oedema)
• dizziness, headache
• palpitations (fast or irregular heartbeat), irregular heart rhythm (arrhythmia)
• high blood pressure
• wheezing or difficulty breathing (bronchospasm)
• constipation, flatulence (excess gas), gastritis (inflammation of the inner lining of the stomach), heartburn, diarrhoea, indigestion (dyspepsia)/stomach discomfort, nausea, vomiting, inflammation of the oesophagus, mouth ulcers
• changes in blood tests related to your liver
• bruising
• weakness and fatigue, flu-like illness

Uncommon

• gastroenteritis (inflammation of the gastrointestinal tract affecting both the stomach and small intestine/gastric flu), cold, urinary tract infection
• changes in laboratory results (reduced number of red blood cells, reduced number of white blood cells, decreased platelets)
• hypersensitivity (allergic reaction including hives, which may be severe enough to require immediate medical attention)
• increased or decreased appetite, weight gain
• anxiety, depression, reduced mental sharpness; seeing, feeling, or hearing things that are not there (hallucinations)
• altered taste, inability to sleep, numbness or tingling, drowsiness
• blurred vision, eye irritation and redness
• ringing in the ears, dizziness (sensation of spinning while standing still)
• abnormal heart rhythm (atrial fibrillation), rapid heart rate, heart failure, sensation of tightness, pressure, or heaviness in the chest (angina pectoris), myocardial infarction
• redness, stroke, mini-stroke (transient ischaemic attack), severe increase in blood pressure, inflammation of blood vessels
• cough, shortness of breath, nosebleed
• stomach swelling, changes in bowel habits, dry mouth, stomach ulcer, inflammation of the inner lining of the stomach which may become severe and lead to bleeding, irritable bowel syndrome, inflammation of the pancreas
• facial swelling, skin rash or itching, skin redness
• muscle cramp/spasm, muscle pain/stiffness
• elevated potassium levels in your blood, changes in blood or urine tests related to your kidneys, serious kidney problems
• chest pain

Rare

• angioedema (allergic reaction with swelling of the face, lips, tongue, and/or throat that may cause difficulty breathing or swallowing, which may be severe enough to require immediate medical attention)/anaphylactic/anaphylactoid reactions including shock (severe allergic reaction requiring immediate medical attention)
• confusion, restlessness
• liver problems (hepatitis)
• low levels of sodium in the blood
• liver disorder, yellowing of the skin and/or eyes (jaundice)
• serious skin reactions

Reporting of adverse effects

If you experience any adverse effect, talk to your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Etoricoxib cinfa

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.

This medicine does not require any special storage conditions.

Medicines must not be disposed of via wastewater or household waste. Dispose of containers and unused medicines at the SIGRE collection point at your pharmacy. If you are in doubt, ask your pharmacist how to dispose of containers and medicines you no longer need. This will help protect the environment.

6. Pack contents and other information

Composition of Etoricoxib cinfa

• The active substance is etoricoxib. Each film-coated tablet contains 30 mg, 60 mg, 90 mg or 120 mg of etoricoxib.

• The other components (excipients) are:

Core: pregelatinized maize starch, microcrystalline cellulose, sodium croscarmellose, colloidal silicon dioxide, hydroxypropylcellulose, magnesium stearate.

Tablet coating: Opadry Y-1-7000 (hypromellose, titanium dioxide, macrogol). The 30 mg, 60 mg and 120 mg tablets also contain yellow iron oxide (E-172) and indigo carmine lake (indigo carmine and aluminium hydroxide) (E-132).

Appearance of the medicinal product and pack contents

Etoricoxib cinfa tablets are available in four strengths:

30 mg film-coated tablets: bluish-green, cylindrical, biconvex tablets marked with the code "E3".

60 mg film-coated tablets: dark green, cylindrical, biconvex tablets marked with the code "E6".

90 mg film-coated tablets: white, cylindrical, biconvex tablets marked with the code "E9".

120 mg film-coated tablets: light green, cylindrical, biconvex tablets marked with the code "E12".

Pack sizes:

30 mg and 60 mg:

Aluminium/aluminium blisters in packs containing 28 film-coated tablets.

90 mg:

Aluminium/aluminium blisters in packs containing 2 and 28 film-coated tablets.

120 mg:

Aluminium/aluminium blisters in packs containing 7 film-coated tablets.

Only some pack sizes may be commercially available.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) - Spain

Manufacturer:

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) - Spain

or

FUNDACIÓN TECNALIA RESEARCH & INNOVATION

Facultad de Farmacia, Paseo de la Universidad, 7,

Vitoria-Gasteiz, 01006 Álava SPAIN

Date of the most recent revision of this leaflet: October 2020

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency of Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Etoricoxib cinfa 30 mg film-coated tablets EFG

You can access detailed and up-to-date information about this medicinal product by scanning with your mobile phone (smartphone) the QR code included in the package leaflet and outer packaging. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/80752/P_80752.html

QR code link: https://cima.aemps.es/cima/dochtml/p/80752/P_80752.html

Etoricoxib cinfa 60 mg film-coated tablets EFG

You can access detailed and up-to-date information about this medicinal product by scanning with your mobile phone (smartphone) the QR code included in the package leaflet and outer packaging. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/80751/P_80751.html

QR code link: https://cima.aemps.es/cima/dochtml/p/80751/P_80751.html

Etoricoxib cinfa 90 mg film-coated tablets EFG

You can access detailed and up-to-date information about this medicinal product by scanning with your mobile phone (smartphone) the QR code included in the package leaflet and outer packaging. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/80753/P_80753.html

QR code link: https://cima.aemps.es/cima/dochtml/p/80753/P_80753.html

Etoricoxib cinfa 120 mg film-coated tablets EFG

You can access detailed and up-to-date information about this medicinal product by scanning with your mobile phone (smartphone) the QR code included in the package leaflet and outer packaging. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/80754/P_80754.html

QR code link: https://cima.aemps.es/cima/dochtml/p/80754/P_80754.html